Navigation Links
Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results
Date:8/13/2009

  • Continued progress on the development of Cardica's C-Port(R) X-CHANGEII(TM), a cartridge-based C-Port system, allowing surgeons to complete up to four anastomoses with the same CO2 powered handle. Cardica expects to launch this product in fiscal 2010, subject to FDA clearance, and believes this product will not only show improved performance but, with significantly reduced cost of goods, will allow Cardica to offer more favorable pricing while improving gross margins;
  • Reported the publication of full results for the PAS-Port system multi-center pivotal trial in The Journal of Thoracic and Cardiovascular Surgery. The data demonstrated that the PAS-Port system met all endpoints and saved approximately five minutes of operating room time when compared to hand-sewn anastomoses; and
  • Started development of the Cardica Microcutter, a multi-fire endolinear microcutter device based on Cardica's proprietary "staple-on-a-strip" technology. This truly innovative staple design is the basis for a new generation of linear staplers under development by Cardica that the company believes could alter the landscape of stapling products. Cardica anticipates that it could launch the first product of this product line in fiscal 2011, subject to completion of trials and receipt of FDA clearance. The microcutter product line will feature reduced shaft diameters to facilitate less invasive surgical procedures. Importantly, Cardica believes that the microcutter product line could be the first and only linear staplers that will allow surgeons to deploy multiple staple lines without the need for the exchange of individual cartridges.
  • Fiscal 2009 Fourth Quarter Financial Results

    Total product revenue was $1.2 million for the fiscal 2009 fourth quarter compared to $1.6 million for the fiscal 2008 fourth quarter. Product revenue decreased as a result of Cardica's smaller direct sales force during t
    '/>"/>

    SOURCE Cardica, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Cardica Announces Proposed Public Offering of Common Stock
    2. Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock
    3. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
    4. Cardica Announces Exercise of Over-Allotment Option
    5. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
    6. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
    7. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
    8. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
    9. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
    10. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
    11. Cardica Names Frederick Bauer Vice President of Operations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)... about the chance of ,overdiagnosis, through the NHS breast ... according to research published in the British Journal ... survey of around 2,200 women, Cancer Research UK scientists ... cent felt they fully understood the information given about ... cancers that would never have gone on to cause ...
    (Date:8/28/2014)... Millennium Treatment Group is excited ... month will be a celebration of the positive ... Along with other treatment facilities and mental health ... the word about this national observance. , National ... of treatment and recovery professionals, and has since ...
    (Date:8/28/2014)... Millennium Treatment Group has noticed a ... workplace. A recent report from the National Council ... drug abuse is costing employers an estimated $81 billion ... to drugs affect their employers and the company they ... workplace, causing expensive problems for their employers, such as ...
    (Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, 2014 (HealthDay ... symptoms of multiple sclerosis (MS), a new study from Argentina ... D, smoking and Epstein Barr virus infection. Our study shows ... MS patients," said lead researcher Dr. Mauricio Farez, of the ... Multiple sclerosis is a disease of the nervous system that ...
    (Date:8/28/2014)... 2014 Testimony began this week ... transvaginal mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ )involving a ... reports. Court documents pending in the U.S. District ... the case was filed on behalf of a ... allegedly due to vaginal mesh complications associated with ...
    Breaking Medicine News(10 mins):Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 4
    ... [Brown University] More than 1.4 million Americans live ... million will need long-term care, whether in a nursing ... an at-home health service provider. , At this time ... on Aging has awarded Brown University a major grant ...
    ... 15 Danny Wright, Chief Executive Officer,of Alliance ... will be featured in an exclusive interview,with ... p.m. EST. The interview,will be posted on ... 16. The interview will cover topics including ...
    ... The Center for State and,Local Government Excellence ... Public Policy and Social Research (IPPSR) at Michigan ... the state,s unfunded retiree health,care liability. Michigan ... billion. To help policy leaders develop thoughtful solutions, ...
    ... NovaBay,Pharmaceuticals, Inc. (AMEX & TSX: NBY), a biopharmaceutical ... or prevention of a wide range of bacterial ... quarter ended September 30, 2007. Net loss ... $1.6 million, or,$0.24 per share, as compared to ...
    ... United States are estimated to already have bone diseases, ... low bone mass, putting them at increased risk for ... Wang, assistant professor of mechanical engineering at the University ... Two of Wang,s aunts have suffered from the insidious ...
    ... when a naturally occurring hormone in your body turns against ... melatonin is a popular supplement you take to ... his team of researchers may have some answers. ... biology and biochemistry at UH, describes his teams findings in ...
    Cached Medicine News:Health News:Brown to create most comprehensive long-term care database 2Health News:Brown to create most comprehensive long-term care database 3Health News:WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard 2Health News:Center For Excellence to Fund Analysis of Michigan State Retiree Health Care Reforms 2Health News:NovaBay announces third quarter 2007 financial results 2Health News:NovaBay announces third quarter 2007 financial results 3Health News:NovaBay announces third quarter 2007 financial results 4Health News:NovaBay announces third quarter 2007 financial results 5Health News:NovaBay announces third quarter 2007 financial results 6Health News:NovaBay announces third quarter 2007 financial results 7Health News:Bad to the bone: UD research to shed light on osteoporosis 2Health News:Bad to the bone: UD research to shed light on osteoporosis 3Health News:The hormone of darkness: melatonin could hurt memory formation at night 2Health News:The hormone of darkness: melatonin could hurt memory formation at night 3
    (Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
    (Date:8/28/2014)... 28, 2014 Nonin Medical, Inc., the inventor ... medical monitoring, today announced that the Food and Drug ... finger pulse oximeter for use in the ... into a telemedicine hub or kiosk through a USB ... pediatric to adult patients. The Model 3231 received EU ...
    (Date:8/28/2014)... Oregon , August 28, 2014 ... Research titled, "DNA diagnostics Market (products, applications, techniques, ... Trends, Opportunities, Growth and Forecast, 2013 - 2020," ... reach $19 billion by 2020 registering a CAGR ... to provide accurate diagnosis and cost effectiveness over ...
    Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
    ... 2011 Quest Diagnostics Incorporated (NYSE: DGX ... and services, today announced the CE mark and European ... test on the 3M™ Integrated Cycler.  The new test, ... technique to eliminate nucleic-acid sample extraction, a time-consuming process ...
    ... N.J., Nov. 1, 2011 MedAvante, Inc., the world,s ... of treatments for central nervous system (CNS) disorders, announced ... 2011 Fifty Fastest Growing Companies. NJBIZ, New ... 50 Fastest Growing Companies in celebration of New Jersey,s ...
    Cached Medicine Technology:Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 2Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe 3MedAvante Is One of NJ's Fastest Growing Companies 2
    Intermittent catheter...
    Intermittent catheter...
    Intermittent catheter...
    Diagnostic and laboratory test reference. Get help with test preparation, interpretation, follow-up, and reimbursement....
    Medicine Products: